Takeda Pharmaceutical Co Ltd ADR (TAK) Stock Analysis

Takeda Pharmaceutical Co Ltd ADR (TAK) is a publicly traded company in the HEALTHCARE sector. It trades at $15.19, carries a market capitalization of $48.00B, a price-to-earnings ratio of 39.97, a dividend yield of 0.04%. This page summarizes the public market data, fundamentals, and frequently asked questions for TAK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

Market Sentiment

Takeda Pharmaceutical Co Ltd ADR currently has a Bullish sentiment score of 0.15.

About Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited (Ticker: TAK) is a leading global biopharmaceutical firm headquartered in Tokyo, Japan, specializing in the research, development, manufacturing, and marketing of innovative pharmaceuticals and healthcare products. With a strong focus on areas such as oncology, gastroenterology, and neuroscience, Takeda leverages its advanced scientific capabilities to drive growth and deliver transformative therapies that address unmet medical needs. The company is commi...

GNG Research Analysis

GNG Research scores Takeda Pharmaceutical Co Ltd ADR (TAK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TAK.

Frequently Asked Questions

What is TAK's current dividend yield?

Takeda Pharmaceutical Co Ltd ADR (TAK) has a current dividend yield of 0.04%.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Co Ltd ADR pays dividends with a current yield of 0.04%.

What is TAK's P/E ratio?

Takeda Pharmaceutical Co Ltd ADR has a price-to-earnings (P/E) ratio of 39.97.

What is TAK's market cap?

Takeda Pharmaceutical Co Ltd ADR (TAK) has a market capitalization of $48.00B with a current stock price of $15.19.